Page last updated: 2024-10-28

hydralazine and Ventricular Fibrillation

hydralazine has been researched along with Ventricular Fibrillation in 1 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Murakawa, Y1
Yamashita, T1
Kanese, Y1
Omata, M1

Other Studies

1 other study available for hydralazine and Ventricular Fibrillation

ArticleYear
Effect of atrial natriuretic peptide on electrical defibrillation efficacy.
    Journal of cardiovascular electrophysiology, 1998, Volume: 9, Issue:9

    Topics: Animals; Atrial Natriuretic Factor; Cyclic GMP; Dogs; Electric Countershock; Electrocardiography; He

1998